Dr. Zhavoronkov is the Founder and CEO of Insilico Medicine, Founder of Deep Longevity, and an adjunct professor of artificial intelligence at the Buck Institute for Research on Aging.

Dr. Zhavoronkov holds a master’s degree in biotechnology from Johns Hopkins and a PhD in Physics and Mathematic...

What if we could decentralize clinical trials, so that any patient, anywhere in the world, could participate?

That’s the mission of Curebase: making effective decentralized clinical trials a reality so that more people can participate in them.

The company’s software platform and virtual staff ...

Can we prevent or even reverse chronic diseases?

That’s the mission of Viome. The company’s platform analyzes all the biochemical activity in your body by looking at your saliva, blood, and stool to give you an accurate picture of your unique health… and combines this with predictive biomarker...

What if healthcare teams could use technology to identify patients with rising risks and prevent costly hospitalizations?

CareSignal’s remote patient monitoring platform and AI-based patient engagement technology enable care teams to get in touch with high-risk patients before their health wors...

I’m excited to continue to interact with you on a deeper level than we normally do in our other monthly webinars.

Join me for another LIVE Ask-Me-Anything session where I have the honor of answering your questions face-to-face!

Did you know that women’s reproductive longevity is perhaps the most important understudied field of medicine?

Its link to our lifespans is unmistakable.

While vastly understudied, ovarian aging and its causes are on the cusp of offering us groundbreaking insights on why we age generally.
...

This will be a deep dive into Bitcoin, to answer all of your questions and give you a clear perspective on its long-term role, and whether you should consider it in your portfolio.

WHO WILL JOIN US:
Michael Saylor, Chairman & CEO of MicroStrategy, major Bitcoin Proponent;
Bill Barhydt, Co-Founde...